BR8907798A - Sequencia recombinavel de dna,sistema de expressao recombinavel,celula hospedeira recombinavel,processo para produzir proteina humana,proteina humana,processo para produzir proteina murina,proteinas murina,proteinas tendo adipsina e atividade em relacao ao complemento d em seres humanos,proteina,composicao farmaceutica,preparacao de anticorpo,processo para diagnosticar deficiencia de adipsina ou complemento d.processo para tratar deficiencia de adipsina,processo para proteger mamiferos,processo para controle de obesidade,processo para controlar obesidade em mamiferos - Google Patents
Sequencia recombinavel de dna,sistema de expressao recombinavel,celula hospedeira recombinavel,processo para produzir proteina humana,proteina humana,processo para produzir proteina murina,proteinas murina,proteinas tendo adipsina e atividade em relacao ao complemento d em seres humanos,proteina,composicao farmaceutica,preparacao de anticorpo,processo para diagnosticar deficiencia de adipsina ou complemento d.processo para tratar deficiencia de adipsina,processo para proteger mamiferos,processo para controle de obesidade,processo para controlar obesidade em mamiferosInfo
- Publication number
- BR8907798A BR8907798A BR898907798A BR8907798A BR8907798A BR 8907798 A BR8907798 A BR 8907798A BR 898907798 A BR898907798 A BR 898907798A BR 8907798 A BR8907798 A BR 8907798A BR 8907798 A BR8907798 A BR 8907798A
- Authority
- BR
- Brazil
- Prior art keywords
- recombinable
- adipsin
- deficiency
- proteins
- obesity
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/277,963 US5223425A (en) | 1987-04-02 | 1988-11-30 | DNA encoding human adipsin with complement D activity |
| PCT/US1989/005374 WO1990006365A1 (en) | 1988-11-30 | 1989-11-21 | Recombinant proteins with adipsin and complement d activities |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR8907798A true BR8907798A (pt) | 1991-08-27 |
Family
ID=23063108
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR898907798A BR8907798A (pt) | 1988-11-30 | 1989-11-21 | Sequencia recombinavel de dna,sistema de expressao recombinavel,celula hospedeira recombinavel,processo para produzir proteina humana,proteina humana,processo para produzir proteina murina,proteinas murina,proteinas tendo adipsina e atividade em relacao ao complemento d em seres humanos,proteina,composicao farmaceutica,preparacao de anticorpo,processo para diagnosticar deficiencia de adipsina ou complemento d.processo para tratar deficiencia de adipsina,processo para proteger mamiferos,processo para controle de obesidade,processo para controlar obesidade em mamiferos |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5223425A (pt) |
| JP (1) | JPH04505098A (pt) |
| AU (1) | AU4808190A (pt) |
| BR (1) | BR8907798A (pt) |
| DK (1) | DK103091A (pt) |
| FI (1) | FI912586A7 (pt) |
| IL (1) | IL92504A0 (pt) |
| WO (1) | WO1990006365A1 (pt) |
| ZA (1) | ZA899161B (pt) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994012645A2 (en) * | 1992-11-25 | 1994-06-09 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | cDNA CLONE FOR HUMAN INDUCIBLE NITRIC OXYDE SYNTHASE AND PROCESS FOR PREPARING SAME |
| US6310034B1 (en) | 1993-05-21 | 2001-10-30 | Ut-Battelle, Llc | Agouti polypeptide compositions |
| US5843652A (en) * | 1993-05-21 | 1998-12-01 | Lockheed Martin Energy Systems, Inc. | Isolation and characterization of Agouti: a diabetes/obesity related gene |
| US6150152A (en) * | 1993-05-28 | 2000-11-21 | Washington University | Human macrophage metalloelastase |
| US5869330A (en) * | 1995-06-05 | 1999-02-09 | Whitehead Institute For Biomedical Research | DNA encoding a novel serum protein produced exclusively in adipocytes |
| WO2002013854A1 (en) * | 2000-08-11 | 2002-02-21 | Temple University Of The Commonwealth System Of Higher Education | Obesity controlling method |
| US7737109B2 (en) * | 2000-08-11 | 2010-06-15 | Temple University Of The Commonwealth System Of Higher Education | Obesity controlling method |
| US6867189B2 (en) * | 2001-07-26 | 2005-03-15 | Genset S.A. | Use of adipsin/complement factor D in the treatment of metabolic related disorders |
| CA2499843A1 (en) * | 2002-09-25 | 2004-04-08 | Genentech, Inc. | Novel compositions and methods for the treatment of psoriasis |
| US20060263774A1 (en) * | 2002-11-01 | 2006-11-23 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
| EP1572116A4 (en) * | 2002-11-26 | 2007-12-12 | Genentech Inc | COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE DISEASES |
| WO2007141004A1 (en) * | 2006-06-09 | 2007-12-13 | Bayer Healthcare Ag | Use of adipsin (adn) as a therapeutic or diagnostic target |
| FR2966734B1 (fr) * | 2010-10-29 | 2014-07-18 | Max Rombi | Composition comprenant au moins une enzyme proteolytique pour son utilisation pour empecher la synthese des triglycerides |
| CN103760341B (zh) * | 2014-01-28 | 2017-05-31 | 成都创宜生物科技有限公司 | 以Adipsin作为标志物制备检测工具的应用及检测工具 |
| US10328131B2 (en) | 2014-03-13 | 2019-06-25 | Dana-Farber Cancer Institute, Inc. | Compositions and methods for regulating pancreatic beta cell function using adipsin |
| EP4032543A1 (en) * | 2021-01-20 | 2022-07-27 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Peptides from the sequence of the complement factor d for medical use, especially for the treatment of ebv-associated diseases |
| US12252629B2 (en) | 2021-10-28 | 2025-03-18 | Kismet Technologies Inc. | Electronic device with self-disinfecting touch screen and method of manufacture |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4684623A (en) * | 1985-05-02 | 1987-08-04 | The Board Of Trustees Of The Cetus Corporation | Use of tumor necrosis factor as a weight regulator |
-
1988
- 1988-11-30 US US07/277,963 patent/US5223425A/en not_active Expired - Fee Related
-
1989
- 1989-11-21 WO PCT/US1989/005374 patent/WO1990006365A1/en not_active Ceased
- 1989-11-21 FI FI912586A patent/FI912586A7/fi not_active Application Discontinuation
- 1989-11-21 JP JP2501337A patent/JPH04505098A/ja active Pending
- 1989-11-21 AU AU48081/90A patent/AU4808190A/en not_active Abandoned
- 1989-11-21 BR BR898907798A patent/BR8907798A/pt not_active Application Discontinuation
- 1989-11-30 IL IL92504A patent/IL92504A0/xx unknown
- 1989-11-30 ZA ZA899161A patent/ZA899161B/xx unknown
-
1991
- 1991-05-30 DK DK103091A patent/DK103091A/da unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK103091A (da) | 1991-07-30 |
| IL92504A0 (en) | 1990-08-31 |
| WO1990006365A1 (en) | 1990-06-14 |
| US5223425A (en) | 1993-06-29 |
| FI912586A0 (fi) | 1991-05-29 |
| ZA899161B (en) | 1990-09-26 |
| FI912586A7 (fi) | 1991-05-29 |
| AU4808190A (en) | 1990-06-26 |
| JPH04505098A (ja) | 1992-09-10 |
| DK103091D0 (da) | 1991-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR8907798A (pt) | Sequencia recombinavel de dna,sistema de expressao recombinavel,celula hospedeira recombinavel,processo para produzir proteina humana,proteina humana,processo para produzir proteina murina,proteinas murina,proteinas tendo adipsina e atividade em relacao ao complemento d em seres humanos,proteina,composicao farmaceutica,preparacao de anticorpo,processo para diagnosticar deficiencia de adipsina ou complemento d.processo para tratar deficiencia de adipsina,processo para proteger mamiferos,processo para controle de obesidade,processo para controlar obesidade em mamiferos | |
| BR8807339A (pt) | Macrocoloide proteinaceo dispersivo em agua,dispersao aquosa,processo para aquecimento de proteinas coagulaveis e produto | |
| DE68903884D1 (de) | Mittel und methode zur bestimmung von spurenmengen an proteinen. | |
| DE3785112D1 (de) | Fahrzeug-regelsystem und methode dafuer. | |
| BR8906988A (pt) | Tetrapiptidio,peptidio,composicao farmaceutica,processo para uso de peptidio e reagente para diagnostico | |
| DE3689525D1 (de) | Neue Polypeptide mit blutgerinnungshemmender Wirkung, Verfahren zu deren Herstellung bzw. Gewinnung, deren Verwendung und diese enthaltende Mittel. | |
| DK173985D0 (da) | Blodkoagulationsinhiberende polypeptider, deres fremstilling eller udvinding, samt anvendelse deraf som diagnostika og reagenser | |
| DE3579099D1 (de) | Dna-sonden mit verbindungsfragment und sondengruppe. | |
| DE3751600D1 (de) | Dreifachredundantes fehlererkennungssystem und entsprechendes anwendungsverfahren. | |
| DE68929551D1 (de) | Menschliche DNase | |
| BR8603413A (pt) | Sistema de controle de maquina e processo para operar maquina | |
| FI871124A7 (fi) | Polypeptidi, DNA ja sen käyttö. | |
| DK317288D0 (da) | Hybridprotein af humant protein c og dets fremstilling samt dna, som koder det | |
| BR8506817A (pt) | Glicoproteina antigenica bovina,anticorpo relacionado e uso na deteccao de gravidez no gado | |
| ATE168135T1 (de) | Diagnose von retinoblastoma | |
| DK300787A (da) | Dna-struktur fra cytomegalivirus, ekspressionsvektor derfor samt dermed kodede proteinstrukturer og disses anvendelse | |
| FI875518L (fi) | Menetelmä kudosproteiini PP4:n puhdistamiseksi | |
| DE68917273D1 (de) | Testmethode und Gerät zur Bestimmung des gesamten Proteins. | |
| FI863626A7 (fi) | DNA-sekvenssejä, yhdistelmä-DNA -molekyylejä ja menetelmiä ihmisen lip okortiinin kaltaisia polypeptidejä. | |
| DE3763265D1 (de) | Betriebssteuersystem und -verfahren. | |
| DE3780335D1 (de) | Prozesssteuerungssystem und -verfahren. | |
| DE3790139D2 (en) | Antiparatypical antibodies, their use for detecting and treating auto-immune diseases | |
| FI873614A7 (fi) | Alhaisen affiniteetin omaava ihmis-Fc -reseptori, sen eristys, rekombinointivalmistus ja puhdistus. | |
| NO972046L (no) | Antistoff mot allogene og xenogene proteiner, deres bruk i diagnose og terapi samt fremgangsmåter for bestemmelse av slike | |
| DE3888715D1 (de) | Reg-Gen und dadurch kodiertes Protein. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD3 | Appl. lapsed due to non-payment of renewal fee | ||
| B15K | Others concerning applications: alteration of classification |
Ipc: C12N 9/64 (2006.01), C07K 16/40 (2006.0 |